Exploring the mechanism of comorbidity in patients with T1DM and COVID-19: Integrating bioinformatics and Mendelian randomization methods
Open Access
- 18 October 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (42) , e40128
Abstract
During the coronavirus disease 2019 (COVID-19) pandemic, the incidence of type 1 diabetes mellitus (T1DM) has increased. Additionally, evidence suggests that individuals with diabetes mellitus may have increased susceptibility to severe acute respiratory syndrome coronavirus 2 infection. However, the specific causal relationships and interaction mechanisms between T1DM and COVID-19 remain unclear. This study aims to investigate the causal relationship between T1DM and COVID-19, utilizing differential gene expression and Mendelian randomization analyses. Differentially expressed gene sets from datasets GSE156035 and GSE171110 were intersected to identify shared genes, analyzed for functional enrichment. Mendelian randomization models were employed to assess causal effects, revealing no direct causal link between T1DM and COVID-19 in the European population (P > .05). Notably, DNA replication and sister chromatid cohesion 1 (DSCC1) showed negative causal associations with both diseases (T1DM: OR = 0.943, 95% CI: 0.898–0.991, P = .020; COVID-19: OR = 0.919, 95% CI: 0.882–0.958, P < .001), suggesting a protective effect against their comorbidity. This genetic evidence highlights DSCC1 as a potential target for monitoring and managing the co-occurrence of T1DM and COVID-19.Keywords
This publication has 57 references indexed in Scilit:
- Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2Archives of Medical Research, 2020
- The role of follicular T helper cells in the onset and treatment of type 1 diabetesInternational Immunopharmacology, 2020
- LncRNA MALAT1 induces the dysfunction of β cells via reducing the histone acetylation of the PDX-1 promoter in type 1 diabetesExperimental and Molecular Pathology, 2020
- Salidroside protects against diabetes mellitus‐induced kidney injury and renal fibrosis by attenuating TGF‐β1 and Wnt1/3a/β‐catenin signallingClinical and Experimental Pharmacology and Physiology, 2020
- Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related TraitsDiabetes Care, 2020
- The heterogeneous pathogenesis of type 1 diabetes mellitusNature Reviews Endocrinology, 2019
- β-Cell DNA Damage Response Promotes Islet Inflammation in Type 1 DiabetesDiabetes, 2018
- Extending Remission and Reversing New-Onset Type 1 Diabetes by Targeted Ablation of Autoreactive T CellsDiabetes, 2018
- B cells in type 1 diabetes mellitus and diabetic kidney diseaseNature Reviews Nephrology, 2017
- Overexpression of Cohesion Establishment Factor DSCC1 through E2F in Colorectal CancerPLOS ONE, 2014